World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
63
Citations
15128
World Ranking
2718
National Ranking
65

Overview

Thomas Klimkait is affiliated with the University of Basel in Switzerland and has a research focus primarily in the fields of Medicine and Immunology and Microbiology. Their work extensively covers subfields such as Infectious Diseases, Virology, Emergency Medicine, Epidemiology, and Molecular Biology.

The scientist's main research topics address several aspects of HIV/AIDS, including HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV/AIDS drug development and treatment, and HIV-related health complications and treatments. Other significant subjects of study include SARS-CoV-2 and COVID-19 Research, HIV, Drug Use, Sexual Risk, and Hepatitis C virus research.

Thomas Klimkait has contributed to numerous peer-reviewed publications, with frequent appearances in specific scientific venues. The most common publication venues include:

  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • The Journal of Infectious Diseases
  • Zenodo (CERN European Organization for Nuclear Research)
  • Journal of Antimicrobial Chemotherapy

Their recent papers feature contributions to diverse high-impact journals and publications. Selected works include:

  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • A highly virulent variant of HIV-1 circulating in the Netherlands, 2022, Science
  • Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV, 2022, Zurich Open Repository and Archive (University of Zurich)
  • Impact of Integrase Inhibitors on Cardiovascular Disease Events in People With Human Immunodeficiency Virus Starting Antiretroviral Therapy, 2023, Clinical Infectious Diseases
  • Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland, 2023, The Lancet Regional Health - Europe

Collaboration is a notable aspect of Thomas Klimkait's research career. Frequent co-authors include:

  • Huldrych F. Günthard
  • Enos Bernasconi
  • Matthias Cavassini
  • Roger D. Kouyos
  • Alexandra Calmy

Best Publications

  • Prospective Study of Polyomavirus Type BK Replication and Nephropathy in Renal-Transplant Recipients

    Hans H Hirsch;Wendy Knowles;Michael Dickenmann;Jakob Passweg

  • Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.

    V Nickeleit;T Klimkait;I F Binet;P Dalquen

  • The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release.

    T Klimkait;K Strebel;M D Hoggan;M A Martin

  • A novel gene of HIV-1, vpu, and its 16-kilodalton product.

    Klaus Strebel;Thomas Klimkait;Malcolm A. Martin

  • Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein.

    K Strebel;T Klimkait;F Maldarelli;M A Martin

  • Combinatorially selected guanosine-quartet structure is a potent inhibitor of human immunodeficiency virus envelope-mediated cell fusion.

    Jacqueline R. Wyatt;Timothy A. Vickers;Joseph L. Roberson;Robert W. Buckheit

  • An inhibitor of the Tat/TAR RNA interaction that effectively suppresses HIV-1 replication

    François Hamy;Eduard R. Felder;Gerhard Heizmann;Janis Lazdins

  • European guidelines on the clinical management of HIV-1 tropism testing

    L.P.R. Vandekerckhove;Annemarie Wensing;Rolf Kaiser;F. Brun-Vézinet

  • Effect of Offering Same-Day ART vs Usual Health Facility Referral During Home-Based HIV Testing on Linkage to Care and Viral Suppression Among Adults With HIV in Lesotho: The CASCADE Randomized Clinical Trial.

    Niklaus D. Labhardt;Niklaus D. Labhardt;Niklaus D. Labhardt;Isaac Ringera;Thabo I. Lejone;Thomas Klimkait

  • New Aza-Dipeptide Analogues as Potent and Orally Absorbed HIV-1 Protease Inhibitors: Candidates for Clinical Development

    Guido Bold;Alexander Fässler;Hans-Georg Capraro;Robert Cozens

  • Estimating the Basic Reproductive Number from Viral Sequence Data

    Tanja Stadler;Roger Kouyos;Viktor von Wyl;Sabine Yerly

  • A prospective trial of structured treatment interruptions in human immunodeficiency virus infection

    Catherine Fagard;Annette Oxenius;Huldrych Günthard;Felipe Garcia

  • Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland

    Roger D. Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.

    François Hamy;Vincent Brondani;Andreas Flörsheimer;Wilhelm Stark

  • A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control

    István Bartha;Jonathan M Carlson;Chanson J Brumme;Paul J McLaren;Paul J McLaren;Paul J McLaren

  • Prospective Monitoring of BK Virus Load after Discontinuing Sirolimus Treatment in a Renal Transplant Patient with BK Virus Nephropathy

    Hans H. Hirsch;Markus Mohaupt;Thomas Klimkait

  • Determinants of HIV-1 broadly neutralizing antibody induction

    Peter Rusert;Roger D Kouyos;Claus Kadelka;Hanna Ebner

  • Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.

    Nadine Bachmann;Chantal von Siebenthal;Valentina Vongrad;Teja Turk

  • Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey

    Sabine Yerly;Viktor von Wyl;Bruno Ledergerber;Jürg Böni

  • Ambiguous Nucleotide Calls From Population-based Sequencing of HIV-1 are a Marker for Viral Diversity and the Age of Infection

    Roger D Kouyos;Viktor von Wyl;Sabine Yerly;Jürg Böni

  • Emergence of HIV-1 Drug Resistance in Previously Untreated Patients Initiating Combination Antiretroviral Treatment: A Comparison of Different Regimen Types

    Viktor von Wyl;Sabine Yerly;Jürg Böni;Philippe Bürgisser

Frequent Co-Authors

Sabine Yerly
Sabine Yerly University of Geneva
Manuel Battegay
Manuel Battegay University Hospital of Basel
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Jürg Böni
Jürg Böni University of Zurich
Enos Bernasconi
Enos Bernasconi Universita della Svizzera Italiana
Matthias Cavassini
Matthias Cavassini University of Lausanne
Roger D. Kouyos
Roger D. Kouyos University of Zurich
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Hansjakob Furrer
Hansjakob Furrer University of Bern
Bruno Ledergerber
Bruno Ledergerber University of Zurich

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to various online degrees and career options beyond traditional lab roles. For those with unique challenges, such as a criminal record, exploring what is the best degree for a convicted felon can provide valuable guidance on accessible educational paths that lead to stable careers.

Many microbiology graduates find rewarding roles in healthcare settings. Careers like becoming a functional medicine nurse practitioner offer opportunities to apply biological knowledge in patient care, with competitive salaries and growing demand. Understanding the functional medicine nurse practitioner salary can help you evaluate this pathway’s potential.

Another promising area linked to microbiology and health sciences is health information management. As a health information manager, you would oversee medical data and ensure accuracy in healthcare documentation. Learning about health information management jobs salary and career pathways can clarify the benefits of this role.

For those interested in coding medical information, obtaining a certified professional coder certification enhances employability in medical billing and coding fields. This certification can open doors to various healthcare organizations, making it a practical complement to your microbiology background.

Best Scientists Citing Thomas Klimkait

Trending Scientists

Recently Published Articles